Comparison of the Pharmacokinetic and Pharmacodynamic Properties of Biocon's Insulin R U-500 With Humulin® R U-500 (US Reference Product) in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2022-06-10
- Last Posted Date
- 2023-05-09
- Lead Sponsor
- Biocon Limited
- Target Recruit Count
- 78
- Registration Number
- NCT05413863
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH 9, Neuss, Germany
Efficacy and Safety of Itolizumab in COVID-19 Complications
- Conditions
- Interventions
- First Posted Date
- 2020-07-17
- Last Posted Date
- 2021-06-14
- Lead Sponsor
- Biocon Limited
- Target Recruit Count
- 32
- Registration Number
- NCT04475588
- Locations
- 🇮🇳
Topiwala National Medical College & B. Y. L. Nair Charitable Hospital,, Mumbai, India
🇮🇳Seth GS Medical College and KEM Hospital, Mumbai, India
🇮🇳All India Institute Of Medical Sciences, New Delhi, India
Evaluation of Pharmacokinetics , Safety, Tolerability and Pharmacodynamics of Biocon Insulin Tregopil
- First Posted Date
- 2019-10-28
- Last Posted Date
- 2022-06-27
- Lead Sponsor
- Biocon Limited
- Target Recruit Count
- 55
- Registration Number
- NCT04141423
- Locations
- 🇩🇪
Profil Mainz GmbH & Co. KG Malakoff-Passage,Rheinstraße 4C D-55116, Mainz, Germany
Comparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R
- Conditions
- Interventions
- First Posted Date
- 2019-07-17
- Last Posted Date
- 2021-07-28
- Lead Sponsor
- Biocon Limited
- Target Recruit Count
- 42
- Registration Number
- NCT04022317
- Locations
- 🇩🇪
Profil Mainz GmbH, Mainz, Germany
Comparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30
- Conditions
- Interventions
- First Posted Date
- 2019-07-17
- Last Posted Date
- 2020-01-30
- Lead Sponsor
- Biocon Limited
- Target Recruit Count
- 78
- Registration Number
- NCT04022291
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH Hellersbergstr. 9 D-41460 Neuss, Neuss, Germany
🇩🇪Profil Mainz GmbH & Co. KG Malakoff-Passage,Rheinstraße 4C D-55116, Mainz, Germany
Comparision of Pharmacokinetic and Pharmacodynamic of Biocon Insulin N and Humulin® N
- Conditions
- Interventions
- First Posted Date
- 2019-07-17
- Last Posted Date
- 2020-01-30
- Lead Sponsor
- Biocon Limited
- Target Recruit Count
- 90
- Registration Number
- NCT04022304
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
Comparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus Patients
- Conditions
- Interventions
- First Posted Date
- 2018-02-13
- Last Posted Date
- 2020-05-15
- Lead Sponsor
- Biocon Limited
- Target Recruit Count
- 143
- Registration Number
- NCT03430856
- Locations
- 🇮🇳
Diacon Hospital, Bangalore, Karnataka, India
Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD
- Conditions
- Interventions
- First Posted Date
- 2018-01-08
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Biocon Limited
- Target Recruit Count
- 51
- Registration Number
- NCT03392961
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients
- Conditions
- Interventions
- First Posted Date
- 2009-12-21
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Biocon Limited
- Target Recruit Count
- 20
- Registration Number
- NCT01035801
- Locations
- 🇮🇳
Bharti Research Institute of Diabetes and Endocrinology, Karnal, Hariyana, India
🇮🇳Bangalore Diabetes Hospital, Bangalore, Karnataka, India
🇮🇳Care Hospital, Hyderabad, Andhra Pradesh, India